4.7 Article

Deleted in Breast Cancer 1 Limits Adipose Tissue Fat Accumulation and Plays a Key Role in the Development of Metabolic Syndrome Phenotype

期刊

DIABETES
卷 64, 期 1, 页码 12-22

出版社

AMER DIABETES ASSOC
DOI: 10.2337/db14-0192

关键词

-

资金

  1. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [DK-084055]
  2. National Institutes of Health (National Institute on Aging) [AG-41122, AG-13925]
  3. American Heart Association [11POST7320060]
  4. Agencia Nacional de Investigacion e Innovacion [DCI-ALA/2011/023-502]

向作者/读者索取更多资源

Obesity is often regarded as the primary cause of metabolic syndrome. However, many lines of evidence suggest that obesity may develop as a protective mechanism against tissue damage during caloric surplus and that it is only when the maximum fat accumulation capacity is reached and fatty acid spillover occurs into to peripheral tissues that metabolic diseases develop. In this regard, identifying the molecular mechanisms that modulate adipocyte fat accumulation and fatty acid spillover is imperative. Here we identify the deleted in breast cancer 1 (DBC1) protein as a key regulator of fat storage capacity of adipocytes. We found that knockout (KO) of DBC1 facilitated fat cell differentiation and lipid accumulation and increased fat storage capacity of adipocytes in vitro and in vivo. This effect resulted in a healthy obesity phenotype. DBC1 KO mice fed a high-fat diet, although obese, remained insulin sensitive, had lower free fatty acid in plasma, were protected against atherosclerosis and liver steatosis, and lived longer. We propose that DBC1 is part of the molecular machinery that regulates fat storage capacity in adipocytes and participates in the turn-off switch that limits adipocyte fat accumulation and leads to fat spillover into peripheral tissues, leading to the deleterious effects of caloric surplus.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Geriatrics & Gerontology

Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice

Ming Xu, Elizabeth W. Bradley, Megan M. Weivoda, Soyun M. Hwang, Tamar Pirtskhalava, Teresa Decklever, Geoffry L. Curran, Mikolaj Ogrodnik, Diana Jurk, Kurt O. Johnson, Val Lowe, Tamar Tchkonia, Jennifer J. Westendorf, James L. Kirkland

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2017)

Article Geriatrics & Gerontology

17 alpha-Estradiol Alleviates Age-related Metabolic and Inflammatory Dysfunction in Male Mice Without Inducing Feminization

Michael B. Stout, Frederik J. Steyn, Michael J. Jurczak, Joao-Paulo G. Camporez, Yi Zhu, John R. Hawse, Diana Jurk, Allyson K. Palmer, Ming Xu, Tamar Pirtskhalava, Glenda L. Evans, Roberta de Souza Santos, Aaron P. Frank, Thomas A. White, David G. Monroe, Ravinder J. Singh, Grace Casaclang-Verzosa, Jordan D. Miller, Deborah J. Clegg, Nathan K. LeBrasseur, Thomas von Zglinicki, Gerald I. Shulman, Tamara Tchkonia, James L. Kirkland

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2017)

Article Gastroenterology & Hepatology

Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2(-/-)) mice

Anja Moncsek, Mohammed S. Al-Suraih, Christy E. Trussoni, Steven P. O'Hara, Patrick L. Splinter, Camille Zuber, Eleonora Patsenker, Piero V. Valli, Christian D. Fingas, Achim Weber, Yi Zhu, Tamar Tchkonia, James L. Kirkland, Gregory J. Gores, Beat Mullhaupt, Nicholas F. LaRusso, Joachim C. Mertens

HEPATOLOGY (2018)

Article Geriatrics & Gerontology

The Clinical Potential of Senolytic Drugs

James L. Kirkland, Tamara Tchkonia, Yi Zhu, Laura J. Niedernhofer, Paul D. Robbins

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)

Article Geriatrics & Gerontology

Cellular Senescence Biomarker p16INK4a+ Cell Burden in Thigh Adipose is Associated With Poor Physical Function in Older Women

Jamie N. Justice, Heather Gregory, Tamar Tchkonia, Nathan K. LeBrasseur, James L. Kirkland, Stephen B. Kritchevsky, Barbara J. Nicklas

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2018)

Review Oncology

Premature Physiologic Aging as a Paradigm for Understanding Increased Risk of Adverse Health Across the Lifespan of Survivors of Childhood Cancer

Kirsten K. Ness, James L. Kirkland, Maria Monica Gramatges, Zhaoming Wang, Mondira Kundu, Kelly McCastlain, Xiujie Li-Harms, Jinghui Zhang, Tamar Tchkonia, Saskia Martine Francesca Pluijm, Gregory T. Armstrong

JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

Senolytics improve physical function and increase lifespan in old age

Ming Xu, Tamar Pirtskhalava, Joshua N. Farr, Bettina M. Weigand, Allyson K. Palmer, Megan M. Weivoda, Christina L. Inman, Mikolaj B. Ogrodnik, Christine M. Hachfeld, Daniel G. Fraser, Jennifer L. Onken, Kurt O. Johnson, Grace C. Verzosa, Larissa G. P. Langhi, Moritz Weigl, Nino Giorgadze, Nathan K. LeBrasseur, Jordan D. Miller, Diana Jurk, Ravinder J. Singh, David B. Allison, Keisuke Ejima, Gene B. Hubbard, Yuji Ikeno, Hajrunisa Cubro, Vesna D. Garovic, Xiaonan Hou, S. John Weroha, Paul D. Robbins, Laura J. Niedernhofer, Sundeep Khosla, Tamara Tchkonia, James L. Kirkland

NATURE MEDICINE (2018)

Review Medicine, General & Internal

Senolytic drugs: from discovery to translation

J. L. Kirkland, T. Tchkonia

JOURNAL OF INTERNAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

Cellular senescence and senolytics: the path to the clinic

Selim Chaib, Tamar Tchkonia, James L. Kirkland

Summary: Cellular senescence has emerged as a promising therapeutic target for disorders across the lifespan; targeting persistent senescent cells causing tissue damage may delay, prevent, or alleviate multiple diseases.

NATURE MEDICINE (2022)

Article Endocrinology & Metabolism

Senescence markers in subcutaneous preadipocytes differ in childhood- versus adult-onset obesity before and after weight loss

Jessica Murphy, Bjorn T. Tam, James L. Kirkland, Tamara Tchkonia, Nino Giorgadze, Tamar Pirtskhalava, Michael A. Tsoukas, Jose A. Morais, Sylvia Santosa

Summary: This study aimed to examine the effects of obesity onset on markers of senescence in subcutaneous adipose tissue (SAT) before and after weight loss. The results showed that individuals with childhood-onset obesity had higher levels of DNA damage and senescence markers in SAT compared to those with adult-onset obesity. Weight loss reduced DNA damage in SAT, but did not affect senescence markers. Overall, weight loss improved the aging state associated with obesity.

OBESITY (2023)

Article Endocrinology & Metabolism

BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH

Ritesh K. Baboota, Aidin Rawshani, Laurianne Bonnet, Xiangyu Li, Hong Yang, Adil Mardinoglu, Tamar Tchkonia, James L. Kirkland, Anne Hoffmann, Arne Dietrich, Jeremie Boucher, Matthias Bluher, Ulf Smith

Summary: Hepatic cell senescence is a key factor in human NAFLD/NASH. BMP4 and Gremlin 1 are identified as novel therapeutic targets.

NATURE METABOLISM (2022)

Article Endocrinology & Metabolism

New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms

Tamar Tchkonia, Allyson K. Palmer, James L. Kirkland

Summary: The elderly population is growing faster worldwide, and age is a major predictor of chronic diseases. Enhancing healthspan and targeting fundamental aging mechanisms may lead to greater benefits than treating age-related diseases individually. More research is needed on interventions for aging processes.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Cell Biology

TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion

Renuka Kandhaya-Pillai, Francesc Miro-Mur, Jaume Alijotas-Reig, Tamara Tchkonia, James L. Kirkland, Simo Schwartz

AGING-US (2017)

Article Cell Biology

New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463

Yi Zhu, Ewald J. Doornebal, Tamar Pirtskhalava, Nino Giorgadze, Mark Wentworth, Heike Fuhrmann-Stroissnigg, Laura J. Niedernhofer, Paul D. Robbins, Tamara Tchkonia, James L. Kirkland

AGING-US (2017)

暂无数据